-
Mashup Score: 0The Cancer News Daily - 3 year(s) ago
The latest in cancer medicine and translational research by Wafik El-Deiry MDPhD
Source: paper.liCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 1A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19 - 3 year(s) ago
Background Although convalescent plasma has been widely used to treat severe coronavirus disease 2019 (COVID-19), data from randomized controlled trials that support its efficacy are limited. Objective To evaluate the clinical efficacy and safety of convalescent plasma among adults hospitalized with severe and critical COVID-19. Design Randomized, double-blind, controlled, multicenter, phase 2…
Source: medRxivCategories: Hem/Oncs, Latest HeadlinesTweet-
A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19 {pre-print} [Mar 13, 202] O’Donnell et al. @medrxivpreprint https://t.co/8SjPiDWKV5 #NCT04359810 #COVID19 HT @ACasadevall1 @DrJPHenderson n=223 https://t.co/6ylPzyrK7M
-
-
Mashup Score: 3JCI - A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19 - 3 year(s) ago
Clinical MedicineCOVID-19 Free access | 10.1172/JCI150646 Beatriz Grinsztejn,4 Matthew J. Cummings,1,3 Jessica E. Justman,2,5,6 Matthew R. Lamb,2,5 Christina M. Eckhardt,1 Neena M. Philip,5 Ying Kuen Cheung,7 Vinay Gupta,8 Esau João,9 Jose Henrique Pilotto,10 Maria Pia Diniz,4 Sandra Wagner Cardoso,4…
Source: www.jci.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
DB-RCT of convalescent plasma in adults w/ severe #COVID19 [May 11, 2021] O’Donnell et al. @jclinicalinvest https://t.co/xstbqV1sWW Pre-print Mar 13, 2021 @medrxivpreprint https://t.co/8SjPiDWKV5 #NCT04359810 HT @ACasadevall1 @DrJPHenderson n=223 https://t.co/4YkR271nDC
-
-
Mashup Score: 1JCI - A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19 - 3 year(s) ago
ResearchIn-Press PreviewCOVID-19 Free access | 10.1172/JCI150646 Beatriz Grinsztejn,2 Matthew J. Cummings,1 Jessica E. Justman,3 Matthew R. Lamb,4 Christina M. Eckhardt,1 Neena M. Philip,3 Ying Kuen Cheung,5 Vinay Gupta,6 Esau João,7 Jose H. Pilotto,8 Maria Pia Diniz,9 Sandra Wagner Cardoso,9…
Source: www.jci.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
DB-RCT of convalescent plasma in adults w/ severe #COVID19 [May 11, 2021] O'Donnell et al. @jclinicalinvest https://t.co/uFzLCLSGIv #NCT04359810 #COVID19ClinicalTrials CP signif lowered 28-day mortality OR 0.44 (95% CI 0.22-0.91, p=0.034) HT @DrJPHenderson
-
-
Mashup Score: 3JCI - A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19 - 3 year(s) ago
ResearchIn-Press PreviewCOVID-19 Free access | 10.1172/JCI150646 Beatriz Grinsztejn,2 Matthew J. Cummings,1 Jessica E. Justman,3 Matthew R. Lamb,4 Christina M. Eckhardt,1 Neena M. Philip,3 Ying Kuen Cheung,5 Vinay Gupta,6 Esau João,7 Jose H. Pilotto,8 Maria Pia Diniz,9 Sandra Wagner Cardoso,9…
Source: www.jci.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
DB-RCT of convalescent plasma in adults w/ severe #COVID19 [May 11, 2021] O'Donnell et al. @jclinicalinvest https://t.co/uFzLCLSGIv #NCT04359810 #COVID19ClinicalTrials CP signif lowered 28-day mortality OR 0.44 (95% CI 0.22-0.91, p=0.034) HT @DrJPHenderson https://t.co/CB45iaOe8K
-
A randomized double-blind controlled trial of convalescent plasma in adults with severe #COVID19 [May 11, 2021] O'Donnell et al. @jclinicalinvest https://t.co/uFzLCLSGIv #NCT04359810 #COVID19ClinicalTrials HT @DrJPHenderson
-
-
Mashup Score: 1A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19 - 3 year(s) ago
Background Although convalescent plasma has been widely used to treat severe coronavirus disease 2019 (COVID-19), data from randomized controlled trials that support its efficacy are limited. Objective To evaluate the clinical efficacy and safety of convalescent plasma among adults hospitalized with severe and critical COVID-19. Design Randomized, double-blind, controlled, multicenter, phase 2…
Source: medRxivCategories: Hem/Oncs, Latest HeadlinesTweet-
A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19 {pre-print} [Mar 13, 202] O’Donnell et al. @medrxivpreprint https://t.co/8SjPiDWKV5 #NCT04359810 #COVID19 HT @ACasadevall1 @DrJPHenderson n=223 https://t.co/YGXxhQJP9R
-
-
Mashup Score: 0A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19 - 3 year(s) ago
Background Although convalescent plasma has been widely used to treat severe coronavirus disease 2019 (COVID-19), data from randomized controlled trials that support its efficacy are limited. Objective To evaluate the clinical efficacy and safety of convalescent plasma among adults hospitalized with severe and critical COVID-19. Design Randomized, double-blind, controlled, multicenter, phase 2…
Source: medRxivCategories: Hem/Oncs, Latest HeadlinesTweet-
A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19 {pre-print} [Mar 13, 202] O’Donnell et al. @medrxivpreprint https://t.co/8SjPiDWKV5 #NCT04359810 #COVID19 HT @ACasadevall1 @DrJPHenderson n=223 https://t.co/a1yBKqUi5P
-
-
Mashup Score: 1A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19 - 3 year(s) ago
Background Although convalescent plasma has been widely used to treat severe coronavirus disease 2019 (COVID-19), data from randomized controlled trials that support its efficacy are limited. Objective To evaluate the clinical efficacy and safety of convalescent plasma among adults hospitalized with severe and critical COVID-19. Design Randomized, double-blind, controlled, multicenter, phase 2…
Source: medRxivCategories: Hem/Oncs, Latest HeadlinesTweet-
A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19 {pre-print} [Mar 13, 202] O’Donnell et al. @medrxivpreprint https://t.co/8SjPiDWKV5 #NCT04359810 #COVID19 HT @ACasadevall1 @DrJPHenderson n=223 https://t.co/sBK0lnK6CC
-
-
Mashup Score: 1A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19 - 3 year(s) ago
Background Although convalescent plasma has been widely used to treat severe coronavirus disease 2019 (COVID-19), data from randomized controlled trials that support its efficacy are limited. Objective To evaluate the clinical efficacy and safety of convalescent plasma among adults hospitalized with severe and critical COVID-19. Design Randomized, double-blind, controlled, multicenter, phase 2…
Source: medRxivCategories: Hem/Oncs, Latest HeadlinesTweet-
A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19 {pre-print} [Mar 13, 202] O’Donnell et al. @medrxivpreprint https://t.co/8SjPiDWKV5 #NCT04359810 #COVID19 HT @ACasadevall1 @DrJPHenderson n=223 https://t.co/JVZXyyFFZu
-
The latest The Cancer News Daily! https://t.co/bfgfKe5h3o Thanks to @NCISymptomMgmt @DrMiguelPerales @mtmdphd #nct04359810 #covid19